Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 5OTHER 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 6Mesothelioma, Malignant 3Uterine Cervical Neoplasms 2Mesothelioma 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Solitary Fibrous Tumor, Pleural 1Sarcoma 1Ovarian Neoplasms 1Gestational Trophoblastic Disease 1Endometrial Neoplasms 1Colorectal Neoplasms 1Chondrosarcoma 1Carcinoma, Ovarian Epithelial 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 31Brachytherapy 13Radiotherapy 12Paclitaxel 10Taxes 6Gemcitabine 6Platinum 51,2-diaminocyclohexaneplatinum II citrate 5Topotecan 4Radiotherapy, Intensity-Modulated 4Radiation 4Carboplatin 4Surgical Procedures, Operative 3Fluorouracil 3Cetuximab 3Vinorelbine 2Radiotherapy, Conformal 2Polymerase Chain Reaction 2Pemetrexed 2Chemotherapy, Adjuvant 2Celecoxib 2Capecitabine 2Amifostine 2sulfan blue 1oncogene protein E7, Human papillomavirus type 16 1iso-sulfan blue 1ethanethiol 1carfilzomib 1brivanib 1Vindesine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Uterine Cervical Neoplasms × Pemetrexed × Clear all
NCT00691301 2018-01-09

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

GOG Foundation

Phase 2 Completed
55 enrolled 10 charts
Gynecologic

Uterine Cervical Neoplasms

NCT00087113 2014-02-14

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

GOG Foundation

Phase 2 Completed
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡